{"SPADE_UN_27045": {"Sequence Information": {"Peptide Name": "", "Sequence": "WRWRWGGRRRRRRR", "Sequence Length": 14, "Biological Activity": ["Anticancer", "Anti-Mammalian Cell"], "Binding Target": "1. Mitochondrial membrane", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [], "Literature": [{"Title": "Iterative Design and in Vivo Evaluation of an Oncolytic Antilymphoma Peptide", "Pubmed ID": "28004928", "Reference": "J Med Chem. 2017;60:146-156", "Author": "Eksteen JJ, Ausbacher D, Simon-Santamaria J, Stiberg T, Cavalcanti-Jacobsen C, Wushur I, Svendsen JS, Rekdal Ø", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/28004928"}], "Mass": 2096.42, "PI": 12.0, "Net Charge": 9, "Hydrophobicity": -3.14, "Frequent Amino Acids": "RWG", "Absent Amino Acids": "ACDEFHIKLMNOPQSTUVY", "Basic Residues": 9, "Acidic Residues": 0, "Hydrophobic Residues": 0, "Polar Residues": 14, "Positive Residues": 9, "Negative Residues": 0, "SPADE ID": "SPADE_UN_27045", "Similar Sequences": [{"SPADE_ID": "SPADE_N_08957", "Similarity": 1.0, "Sequence": "WGRRGWGPGRRYWWRWR"}, {"SPADE_ID": "SPADE_N_09962", "Similarity": 1.0, "Sequence": "VGALAVVVWRWRWRW"}, {"SPADE_ID": "SPADE_N_10115", "Similarity": 1.0, "Sequence": "WWRWRW"}], "Hemolytic Activity": "Human fibroblasts MRC-5:IC50=70±18 µM,Human erythrocytes:50% Hemolysis=>300 µM,Human PBMC:IC50=7±1 µM", "Target Organism": "Mouse lymphoma A20(IC50=4±2µM),Human lymphoma Ramos(IC50=9±3µM),Human Myeloma U266(IC50=10±1µM),Human Large Cell Lymphoma SU-DHL-6(IC50=4±0µM),Human Burkitts Lymphoma NAMALWA(IC50=4±1µM),Human lymphoblastic leukemia CCRF-CEM(IC50=8±1µM),Human T lymphoma cells Hut-78(IC50=5±0µM),Human T cell leukemia MT-4(IC50=4±0µM),Human Neuroblastoma SK-N-BE(IC50=16±6µM),Human neuroblastoma SH-SY5Y(IC50=12±4µM),Human prostate cancer DU145(IC50=20±5µM),Human colon adenocarcinoma HT29(IC50=14±0µM),Human hepatocellular carcinoma HepG2(IC50=90±23µM),Human melanoma A375(IC50=20±1µM),Mouse skin melanoma B16-F10(IC50=105±17µM)"}}}